Ipswich Investment Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,650
Closed -$760K 153
2018
Q1
$760K Sell
9,650
-2,850
-23% -$210K 0.32% 79
2017
Q4
$853K Sell
12,500
-1,950
-13% -$101K 0.36% 73
2017
Q3
$581K Sell
14,450
-1,900
-12% -$73.3K 0.26% 85
2017
Q2
$650K Sell
16,350
-7,850
-32% -$287K 0.3% 77
2017
Q1
$780K Sell
24,200
-3,700
-13% -$92.3K 0.34% 71
2016
Q4
$494K Buy
27,900
+7,500
+37% +$162K 0.22% 86
2016
Q3
$476K Sell
20,400
-1,400
-6% -$31.8K 0.23% 86
2016
Q2
$407K Hold
21,800
0.2% 93
2016
Q1
$381K Buy
21,800
+9,400
+76% +$151K 0.18% 86
2015
Q4
$261K Hold
12,400
0.12% 114
2015
Q3
$229K Buy
+12,400
New +$310K 0.11% 123

Other funds holding FMI

Ipswich Investment Management's FMI Position: Q2 2018 in Review

Ipswich Investment Management sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 9,650 shares — an estimated $760K sold.

Ipswich Investment Management first reported a position in FMI in Q3 2015 and held it in 11 quarters. The position peaked at $853K in Q4 2017. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

  • Ipswich Investment Management reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
  • Ipswich Investment Management sold 9,650 Foundation Medicine, Inc. shares in Q2 2018, an estimated $760K.
  • Ipswich Investment Management first reported a position in Foundation Medicine, Inc. in Q3 2015 and held it in 11 quarters.
  • Ipswich Investment Management's Foundation Medicine, Inc. position peaked at $853K in Q4 2017.
  • 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on Ipswich Investment Management's 13F filing for Q2 2018, filed 18 Jul 2018.